Video | Agriculture | Confidence | Economy | Energy | Employment | Finance | Media | Property | RBNZ | Science | SOEs | Tax | Technology | Telecoms | Tourism | Transport | Search

 

Quayside Holdings Takes Significant Stake in HoneyLab

Quayside Holdings Takes Significant Stake in HoneyLab

Deal gives Quayside a significant stake in the rapidly-growing BoP healthcare company 22 June 2016 – Quayside Holdings, has today announced that they have taken a significant stake in the Bay of Plenty-based healthcare company HoneyLab. The investment, facilitated by Northington Partners, allows HoneyLab to rapidly grow its R&D and commercialisation programmes.

HoneyLab CEO Laurence Greig said that after considering its options in relation to capital raising, including both local and overseas investors, HoneyLab felt that Quayside Holdings were the perfect partner. “Quayside present us with an investor that adds so much more than just capital”, he said. “Their understanding and support for our strategy of developing licensable IP was instant”.

Scott Hamilton, the Chief Executive of Quayside Holdings, said that “we are excited by the potential for HoneyLab and were drawn to the company by its focus on innovation”.

HoneyLab are a Bay of Plenty-based healthcare company developing products for skin conditions, pain, nutrition and even the common cold. The company is well advanced in discussions with global consumer healthcare pharmaceutical companies on licensing its patented technology. HoneyLab products are in demand after a series of strongly positive clinical trial results which have shown them to be effective for conditions including acne, rosacea and cold sores. CEO Laurence Greig said that as well as having more than 10 products currently in market, HoneyLab had a large pipeline of products undergoing research and development and that the investment from Quayside would accelerate their development and readiness for commercial release.

Quayside CEO Scott Hamilton sees the investment as complimentary to its existing portfolio with considerable growth potential. Similar to recent direct investments, HoneyLab provides a significant value-add opportunity in the agribusiness sector as identified in the Toi Moana Bay of Plenty Growth Study.

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

By May 2018: Wider, Earlier Microbead Ban

The sale and manufacture of wash-off products containing plastic microbeads will be banned in New Zealand earlier than previously expected, Associate Environment Minister Scott Simpson announced today. More>>

ALSO:

Snail-ier Mail: NZ Post To Ditch FastPost

New Zealand Post customers will see a change to how they can send priority mail from 1 January 2018. The FastPost service will no longer be available from this date. More>>

ALSO:

Property Institute: English Backs Of Debt To Income Plan

Property Institute of New Zealand Chief Executive Ashley Church is applauding today’s decision, by Prime Minister Bill English, to take Debt-to-income ratios off the table as a tool available to the Reserve Bank. More>>

ALSO:

Divesting: NZ Super Fund Shifts Passive Equities To Low-Carbon

The NZ$35 billion NZ Super Fund’s NZ$14 billion global passive equity portfolio, 40% of the overall Fund, is now low-carbon, the Guardians of New Zealand Superannuation announced today. More>>

ALSO:

Split Decision - Appeal Planned: EPA Allows Taranaki Bight Seabed Mine

The Decision-making Committee, appointed by the Board of the Environmental Protection Authority to decide a marine consent application by Trans-Tasman Resources Ltd, has granted consent, subject to conditions, for the company to mine iron sands off the South Taranaki Bight. More>>

ALSO: